首页> 外文期刊>Nature >Lkb1 regulates quiescence and metabolic homeostasis of haematopoietic stem cells
【24h】

Lkb1 regulates quiescence and metabolic homeostasis of haematopoietic stem cells

机译:Lkb1调节造血干细胞的静止和代谢稳态

获取原文
获取原文并翻译 | 示例
       

摘要

The capacity to fine-tune cellular bioenergetics with the demands of stem-cell maintenance and regeneration is central to normal development and ageing, and to organismal survival during periods of acute stress. How energy metabolism and stem-cell homeostatic processes are coordinated is not well understood. Lkb1 acts as an evolutionarily conserved regulator of cellular energy metabolism in eukaryotic cells and functions as the major upstream kinase to phosphorylate AMP-activated protein kinase (AMPK) and 12 other AMPK-related kinases. Whether Lkb1 regulates stem-cell maintenance remains unknown. Here we show that Lkb1 has an essential role in haematopoietic stem cell (HSC) homeostasis. We demonstrate that ablation of Lkb1 in adult mice results in severe pancyto-penia and subsequent lethality. Loss of Lkb1 leads to impaired survival and escape from quiescence of HSCs, resulting in exhaustion of the HSC pool and a marked reduction of HSC repopulating potential in vivo. Lkb1 deletion has an impact on cell proliferation in HSCs, but not on more committed compartments, pointing to context-specific functions for Lkb1 in haematopoiesis. The adverse impact of Lkbl deletion on haematopoiesis was predominantly cell-autonomous and mTOR complex 1 (mTORC1)-independent, and involves multiple mechanisms converging on mitochondrial apop-tosis and possibly downregulation of PGC-1 coactivators and their transcriptional network, which have critical roles in mitochondrial biogenesis and function. Thus, Lkb1 serves as an essential regulator of HSCs and haematopoiesis, and more generally, points to the critical importance of coupling energy metabolism and stem-cell homeostasis.
机译:根据干细胞维持和再生的需求,微调细胞生物能学的能力对于正常发育和老化以及急性应激期间的生物存活至关重要。能量代谢和干细胞体内平衡过程如何协调尚不清楚。 Lkb1充当真核细胞中细胞能量代谢的进化保守调节剂,并充当磷酸化AMP激活的蛋白激酶(AMPK)和其他12种AMPK相关激酶的主要上游激酶。 Lkb1是否调节干细胞维持尚不清楚。在这里,我们显示Lkb1在造血干细胞(HSC)稳态中具有重要作用。我们证明了成年小鼠Lkb1的消融导致严重的全血细胞减少和随后的致死性。 Lkb1的丢失导致生存能力受损,并从HSC静止状态逃逸,导致HSC池耗尽,体内HSC繁殖潜力显着降低。 Lkb1删除对HSC中的细胞增殖有影响,但对更明确的区室没有影响,这表明造血功能中Lkb1的上下文特定功能。 Lkb1删除对造血的不利影响主要是细胞自主性和mTOR complex 1(mTORC1)独立的,并涉及线粒体凋亡和可能下调PGC-1共激活因子及其转录网络的多种机制,这些机制具有关键作用在线粒体的生物发生和功能。因此,Lkb1是HSC和造血功能的重要调节剂,更普遍地,它指出了将能量代谢与干细胞动态平衡耦合起来的至关重要性。

著录项

  • 来源
    《Nature》 |2010年第7324期|p.701-704|共4页
  • 作者单位

    Belfer Institute for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA,epartment of Medical Oncology, Dana-Farber Cancer Institute, Boston. Massachusetts 02115, USA,Department of Medicine and Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA;

    rnBelfer Institute for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA,epartment of Medical Oncology, Dana-Farber Cancer Institute, Boston. Massachusetts 02115, USA,Department of Medicine and Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA;

    rnBelfer Institute for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA,epartment of Medical Oncology, Dana-Farber Cancer Institute, Boston. Massachusetts 02115, USA,Department of Medicine and Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA;

    rnBelfer Institute for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA,epartment of Medical Oncology, Dana-Farber Cancer Institute, Boston. Massachusetts 02115, USA,Department of Medicine and Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA;

    rnBelfer Institute for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA,epartment of Medical Oncology, Dana-Farber Cancer Institute, Boston. Massachusetts 02115, USA,Department of Medicine and Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA;

    rnBelfer Institute for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA,epartment of Medical Oncology, Dana-Farber Cancer Institute, Boston. Massachusetts 02115, USA,Department of Medicine and Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA;

    rnBelfer Institute for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA,epartment of Medical Oncology, Dana-Farber Cancer Institute, Boston. Massachusetts 02115, USA,Department of Medicine and Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA;

    rnBelfer Institute for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA,epartment of Medical Oncology, Dana-Farber Cancer Institute, Boston. Massachusetts 02115, USA,Department of Medicine and Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA;

    rnBelfer Institute for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA,epartment of Medical Oncology, Dana-Farber Cancer Institute, Boston. Massachusetts 02115, USA,Department of Medicine and Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA;

    rnBelfer Institute for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA,epartment of Medical Oncology, Dana-Farber Cancer Institute, Boston. Massachusetts 02115, USA,Department of Dermatology, Harvard Medical School, Boston, Massachusetts 02115,USA;

    rnBelfer Institute for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA,epartment of Medical Oncology, Dana-Farber Cancer Institute, Boston. Massachusetts 02115, USA,Department of Medicine and Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 02:55:22

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号